source
- Jury deliberates conflicting accounts in David Sabatini misconduct trial at Whitehead InstituteA Boston jury is hearing a civil case that pits two very different narratives about the conduct of renowned molecular biologist David Sabatini. The three‑week trial has focused on accusations that…
- Estuary sails into kidney disease space with $103M for gene therapiesEstuary Biotherapeutics is seeking to address the root cause of autosomal dominant polycystic kidney disease with two gene therapy programs based on science from Yale.BioSpace · 25d ago↗ source
- OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia